Suppr超能文献

对于危重症患者肾功能的监测,4小时肌酐清除率比血肌酐更具优势。

Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients.

作者信息

Pickering John W, Frampton Christopher M, Walker Robert J, Shaw Geoffrey M, Endre Zoltán H

出版信息

Crit Care. 2012 Jun 19;16(3):R107. doi: 10.1186/cc11391.

Abstract

INTRODUCTION

Acute kidney injury (AKI) diagnosis is based on an increase in plasma creatinine, which is a slowly changing surrogate of decreased glomerular filtration rate. We investigated whether serial creatinine clearance, a direct measure of the glomerular filtration rate, provided more timely and accurate information on renal function than serial plasma creatinine in critically ill patients.

METHODS

Serial plasma creatinine and 4-hour creatinine clearance were measured 12-hourly for 24 hours and then daily in 484 patients. AKI was defined either as > 50% increase in plasma creatinine from baseline, or > 33.3% decrease in creatinine clearance. The diagnostic and predictive performance of the two AKI definitions were compared.

RESULTS

Creatinine clearance decrease diagnosed AKI in 24% of those not diagnosed by plasma creatinine increase on entry. These patients entered the ICU sooner after insult than those diagnosed with AKI by plasma creatinine elevation (P = 0.0041). Mortality and dialysis requirement increased with the change in creatinine clearance-acute kidney injury severity class (P = 0.0021). Amongst patients with plasma creatinine < 1.24 mg/dl on entry, creatinine clearance improved the prediction of AKI considerably (Net Reclassification Improvement 83%, Integrated Discrimination Improvement 0.29). On-entry, creatinine clearance associated with AKI severity and duration (P < 0.0001) predicted dialysis need (area under the curve: 0.75) and death (0.61). A > 33.3% decrease in creatinine clearance over the first 12 hours was associated with a 2.0-fold increased relative risk of dialysis or death.

CONCLUSIONS

Repeated 4-hour creatinine clearance measurements in critically ill patients allow earlier detection of AKI, as well as progression and recovery compared to plasma creatinine.

TRIAL REGISTRATION

Australian New Zealand Clinical Trials Registry ACTRN012606000032550.

摘要

引言

急性肾损伤(AKI)的诊断基于血浆肌酐水平的升高,而血浆肌酐是肾小球滤过率降低的一个变化缓慢的替代指标。我们研究了在危重症患者中,作为肾小球滤过率直接测量指标的连续肌酐清除率,相较于连续血浆肌酐水平,是否能提供关于肾功能更及时、准确的信息。

方法

对484例患者每12小时测量一次连续血浆肌酐水平和4小时肌酐清除率,持续24小时,之后每天测量一次。AKI的定义为血浆肌酐水平较基线升高>50%,或肌酐清除率降低>33.3%。比较了这两种AKI定义的诊断和预测性能。

结果

肌酐清除率降低诊断出了24%入院时血浆肌酐水平升高未诊断出的AKI患者。这些患者在受伤后比因血浆肌酐升高诊断为AKI的患者更早进入重症监护病房(P = 0.0041)。死亡率和透析需求随着肌酐清除率 - 急性肾损伤严重程度分级的变化而增加(P = 0.0021)。在入院时血浆肌酐<1.24 mg/dl的患者中,肌酐清除率显著改善了AKI的预测(净重新分类改善83%,综合判别改善0.29)。入院时,与AKI严重程度和持续时间相关的肌酐清除率(P < 0.0001)可预测透析需求(曲线下面积:0.75)和死亡(0.61)。在最初12小时内肌酐清除率降低>33.3%与透析或死亡的相对风险增加2.0倍相关。

结论

与血浆肌酐相比,对危重症患者重复测量4小时肌酐清除率能更早检测出AKI,以及其进展和恢复情况。

试验注册

澳大利亚和新西兰临床试验注册中心ACTRN012606000032550 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/868e/3580664/35c3f3eb9267/cc11391-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验